Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

(Darryl Fonseka/iStock via Getty Images Plus)

Potential COVID-19 treatment to kick off Phase III trial

Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.

Survey: pandemic viewed as catalyst for positive change in trials

According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.

Speaking the language of diverse patient populations is vital: TransPerfect

A leader from the language and tech solutions firm explains how multilingual support can improve patient recruitment and other aspects of clinical trials.

RWD from community registries adds long COVID understanding: IQVIA

An epidemiologist from the healthcare data specialist offers perspective on how real-world data can help get to the heart of long-lasting COVID research.

Global Genes partners to elevate equity for rare disease patients

The radvocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.